Teva Pharmaceutical Industries EPS - Earnings per Share 2010-2024 | TEVA

Teva Pharmaceutical Industries earnings per share (EPS) for the twelve months ending September 30, 2024 was $-0.84, a 60% decline year-over-year.

  • Teva Pharmaceutical Industries EPS for the quarter ending September 30, 2024 was $-0.39, a 750% decline year-over-year.
  • Teva Pharmaceutical Industries 2023 annual EPS was $-0.5, a 77.27% decline from 2022.
  • Teva Pharmaceutical Industries 2022 annual EPS was $-2.2, a 678.95% decline from 2021.
  • Teva Pharmaceutical Industries 2021 annual EPS was $0.38, a 110.44% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Teva Pharmaceutical Industries EPS - Earnings per Share 2010-2024 | TEVA

  • Teva Pharmaceutical Industries EPS for the quarter ending September 30, 2024 was $-0.39, a 750% decline year-over-year.
  • Teva Pharmaceutical Industries 2023 annual EPS was $-0.5, a 77.27% decline from 2022.
  • Teva Pharmaceutical Industries 2022 annual EPS was $-2.2, a 678.95% decline from 2021.
  • Teva Pharmaceutical Industries 2021 annual EPS was $0.38, a 110.44% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.9B
BridgeBio Pharma (BBIO)$4.4B
Bausch Health Cos (BHC)$2.9B
Amphastar Pharmaceuticals (AMPH)$2.2B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$506M
Personalis (PSNL)$245M
Assembly Biosciences (ASMB)$96M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M